|
|
|
|
|
|
by DuskStar
2299 days ago
|
|
|
The Nature article actually mentions the drug in question - camostat mesylate - as one of the TMPRSS2 inhibitors under investigation. (And given how often "this should work, for sure!" drug trials fail to pan out, I'm not sure that "this works in theory, here's why" is that good of an indicator) |
|
|